Position 5-7: Finalization

Lower GI

Select the specific approach and device combination to identify the exact billable procedure code.

Approach 7

Via Natural or Artificial Opening

Device 3

XW0H738 Introduction Lower GI to New Technology Group 8 with Maribavir Anti-infective, Via Natural or Artificial Opening Approach

Device K

XW0H7K8 Introduction Lower GI to New Technology Group 8 with Sabizabulin, Via Natural or Artificial Opening Approach

Device M

XW0H7M6 Introduction Lower GI to New Technology Group 6 with Baricitinib, Via Natural or Artificial Opening Approach

Device R

XW0H7R7 Introduction Lower GI to New Technology Group 7 with Fostamatinib, Via Natural or Artificial Opening Approach

Device X

XW0H7X8 Introduction Lower GI to New Technology Group 8 with Broad Consortium Microbiota-based Live Biotherapeutic Suspension, Via Natural or Artificial Opening Approach

Approach 8

Via Natural or Artificial Opening Endoscopic

Device 8

XW0H886 Introduction Lower GI to New Technology Group 6 with Mineral-based Topical Hemostatic Agent, Via Natural or Artificial Opening Endoscopic Approach